ES8707532A1 - Procedimiento de obtencion de derivados de piracino (2', 3'-3, 4)pirido(1, 2-a)indol - Google Patents

Procedimiento de obtencion de derivados de piracino (2', 3'-3, 4)pirido(1, 2-a)indol

Info

Publication number
ES8707532A1
ES8707532A1 ES529131A ES529131A ES8707532A1 ES 8707532 A1 ES8707532 A1 ES 8707532A1 ES 529131 A ES529131 A ES 529131A ES 529131 A ES529131 A ES 529131A ES 8707532 A1 ES8707532 A1 ES 8707532A1
Authority
ES
Spain
Prior art keywords
pyrazino
pyrido
indole derivatives
derivatives
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529131A
Other languages
English (en)
Other versions
ES529131A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES529131A0 publication Critical patent/ES529131A0/es
Publication of ES8707532A1 publication Critical patent/ES8707532A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE PIRACINO 2K,3K-3,4 PIRIDO 1,2-A INDOL. COMPRENDE: A) SOMETER A ALQUILACION, EN LA EXTENSION REQUERIDA EL COMPUESTO DE FORMULA (II), EN UN DISOLVENTE, COMO DIOXANO, ENTRE 15 Y 30JC, DURANTE 15 A 30 HORAS. SIENDO: R1, H, HAL Y OTROS; Y R2, ALQUILO INFERIOR DE C 1 A 3, O H; Y B) REDUCIR EL PRODUCTO OBTENIDO EN A) CON BOROHIDRURO SODICO, EN UN ALCANOL INFERIOR, METANOL, COMO DISOLVENTE, CON UNA PEQUEÑA CANTIDAD DE AGUA, DURANTE 1 A 5 HORAS Y ENTRE 10 Y 30JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) O UNA SAL DE ADICION DE ACIDO RESPECTIVA TERAPEUTICAMENTE ACEPTABLE. SIENDO: E3 Y R4, ALQUILO INFERIOR, ALQUENILO INFERIOR, ALQUINILO INFERIOR Y OTROS.SE UTILIZA EN FARMACOLOGIA COMO ANTIHIPERTENSIVO EN MAMIFEROS.
ES529131A 1983-01-26 1984-01-25 Procedimiento de obtencion de derivados de piracino (2', 3'-3, 4)pirido(1, 2-a)indol Expired ES8707532A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/461,095 US4482714A (en) 1983-01-26 1983-01-26 Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives

Publications (2)

Publication Number Publication Date
ES529131A0 ES529131A0 (es) 1985-11-16
ES8707532A1 true ES8707532A1 (es) 1985-11-16

Family

ID=23831210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529131A Expired ES8707532A1 (es) 1983-01-26 1984-01-25 Procedimiento de obtencion de derivados de piracino (2', 3'-3, 4)pirido(1, 2-a)indol

Country Status (10)

Country Link
US (1) US4482714A (es)
EP (1) EP0115920A3 (es)
JP (1) JPS59141580A (es)
KR (1) KR840007227A (es)
AU (1) AU2376884A (es)
DK (1) DK33684A (es)
ES (1) ES8707532A1 (es)
GR (1) GR81736B (es)
IE (1) IE840119L (es)
ZA (1) ZA84394B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515949A (en) * 1983-01-26 1985-05-07 American Home Products Corporation [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals
US4624954A (en) * 1985-12-20 1986-11-25 American Home Products Corporation 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments
US4665183A (en) * 1985-12-20 1987-05-12 American Home Products Corp. Process for preparing 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof useful for the treatment of cognitive impairments
US7297289B2 (en) * 2001-03-26 2007-11-20 Nisshinbo Industries, Inc. Ionic liquids, electrolyte salts for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
US3850934A (en) * 1973-06-08 1974-11-26 Hoffmann La Roche 6,7,8,9-tetrahydro-7a,11a-ethanooxyindolo(1,2-h)(1,7)naphthyridin-10(11h)-ones
DE2703920A1 (de) * 1976-02-05 1977-08-11 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung

Also Published As

Publication number Publication date
US4482714A (en) 1984-11-13
GR81736B (es) 1984-12-12
DK33684A (da) 1984-07-27
IE840119L (en) 1984-07-26
EP0115920A2 (en) 1984-08-15
JPS59141580A (ja) 1984-08-14
ES529131A0 (es) 1985-11-16
ZA84394B (en) 1985-09-25
AU2376884A (en) 1984-08-02
DK33684D0 (da) 1984-01-25
EP0115920A3 (en) 1986-02-05
KR840007227A (ko) 1984-12-06

Similar Documents

Publication Publication Date Title
AU591125B2 (en) Therapeutic nucleosides
HUT69407A (en) Process for producing quinolin-4-amine-and 1h-imidazo[4,5-c]quinolin-4-amine derivatives as intermediates
AU2454788A (en) N-substituted derivatives of 1-desoxynojirimycin 1- desoxymannojirimycin, processes for their preparation and their use in medicaments
ES2145318T3 (es) Imidazo(4,5-c)quinolin-aminas.
CA2083274A1 (en) The pharmacological use of certain cystine derivatives
ES8506004A1 (es) Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
HUT47276A (en) Process for producing pyrazolo/1,5-a/pyrimidine derivatives and pharmaceutical compositions containing them
NZ218880A (en) Pyrido(2,3-b)indole-3-carboxylic acid derivatives and pharmaceutical compositions thereof
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
ES8707532A1 (es) Procedimiento de obtencion de derivados de piracino (2', 3'-3, 4)pirido(1, 2-a)indol
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
NZ229023A (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation
ES8201170A1 (es) Procedimiento de preparacion de derivados vincaminicos
AR240674A1 (es) Procedimiento para la preparacion de derivados del acido fenil-2-imidazo(1,2-a)quinoleinacetico y sus sales
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
AU591896B2 (en) (-)-1 Beta-Ethyl-1 alpha- hydroxymethyl-1,2,3,4,6,7,12, 12balpha octahydroindolo (2,3-a) quinolizine, process for its preparation and pharmaceutical compositions containing same
IE813100L (en) Naphthyridine derivatives
ES8307811A1 (es) "procedimiento para la preparacion de nuevas imidazo 1,2-a pirimidinas".
IL84112A0 (en) Derivatives of imidazo(4,5-b)pyridinone-2,their preparation and therapeutic use
FI93121B (fi) Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
AU585340B2 (en) 12b-substituted 1-hydroxymethyl-octahydroindolo-``2,3-a`` quinolizine derivatives, process for their preparation and pharmaceutical compositions containing them
NZ219403A (en) 1,3,4,9-tetrahydropyrano(3,4-b indole-1-acetic acid derivatives and pharmaceutical compositions
ZA894386B (en) Process for the preparation of n-(23-vinblastinoyl)derivatives of 1-amino methylphosphonic acid
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær